Role of the Autonomic Nervous System in HIV-Lipodystrophy

Autonomic Nervous System Activity in the Pathogenesis of the Lipodystrophy Syndrome in HIV-Infected Patients.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00149097

Enrollment

Registered

2005-09-08

Start date

2005-03-31

Completion date

2007-01-31

Last updated

2008-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Lipodystrophy-Syndrome

Brief summary

The study aims to characterise the influence of the autonomic nervous system activity on the development of the lipodystrophy syndrome in HIV-infected patients by measuring heart rate variability and various metabolic pathways in HIV patients receiving highly active antiretroviral therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* HIV-infection * Age above 18 years * No AIDS defining event during last 6 months * No infection during last 6 weeks * No concommitant drug interfering with insulin sensitivity and ANS-activity

Countries

Germany

Outcome results